Palisade Bio

Price & Volume

Stats

52W Range	$0.60-$4.65
Market Cap	$3.7M
Shares Short	949,045

Financials

Revenue (12 Mos)	$0
Revenue Growth (YoY)	0%
Gross Profit (12 Mos)	$0
Diluted EPS	-$6.07

News

Yahoo Finance • 11 days ago

Palisade Bio Appoints Emil Chuang, MB BS FRACP to its Board of Directors

Yahoo Finance • 3 months ago

Palisade Bio Completes Dosing in Phase 1a Portion of Ongoing Phase 1a/b Study of PALI-2108

Yahoo Finance • 4 months ago

Palisade Bio Commences Dosing in First Ulcerative Colitis Patient Cohort in Ongoing Phase 1a/b Study of PALI-2108

Yahoo Finance • 5 months ago

Palisade Bio, Inc. Announces Receipt of Cash Proceeds from Canada’s SR&ED Tax Incentive Program for Reimbursement of Development Costs of PALI-2108 for Treatment of Ulcerative Colitis (UC)

About

CEO	Mr. J. D. Finley
CFO	Mr. J. D. Finley
Address	7750 El Camino Real, Carlsbad, CA, United States, 92009
Sector	Healthcare
Industry	Biotechnology
Full-Time Employees	8